Distribution of the −1117 interleukin (IL) 10 polymorphism in healthy controls and heavy drinkers with and without advanced liver disease
| Subjects | AA | AG | GG |
| Controls (n=212) | 44 (20.8%) | 102 (48.1%) | 66 (31.1%) |
| AALD (n=285) | 72 (25.3%) | 149 (52.3%) | 64 (22.5%) |
| NALD (n=107) | 23 (21.5%) | 53 (49.5%) | 31 (29.0%) |
AALD, advanced alcoholic liver disease; NALD, no evidence of alcoholic liver disease or steatosis only.